AMICUS THERAPEUTICS, INC. - Common Stock (FOLD)

Historical Holders from Q1 2014 to Q3 2025

Symbol: FOLD on Nasdaq
Type / Class: Equity / Common Stock
Shares outstanding: 308,713,740
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 312,156,065
Holdings value: $2,459,923,997
% of all portfolios: 0.005%
Number of holders: 282
Number of buys: 154
Number of sells: -125
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
VANGUARD GROUP INC	10%		$274,137,801		30,871,374		The Vanguard Group	28 Nov 2025
WELLINGTON MANAGEMENT GROUP LLP	9.5%		$214,034,195		28,461,994		Wellington Management Group LLP	31 Dec 2024
BlackRock, Inc.	7.4%	-21.1%	$171,198,846	-$38,641,761	22,765,804	-18.4%	BlackRock, Inc.	31 Mar 2025
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC	5.2%	+6%	$125,877,122	+$9,421,352	15,974,254	+8.1%	WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC	30 Sep 2025
Avoro Capital Advisors LLC	4.87%	-26.1%	$118,397,000	-$43,143,000	15,025,000	-26.7%	Avoro Capital Advisors LLC	30 Sep 2025
Redmile Group, LLC	4.6%		$106,667,402		14,184,495		Redmile Group, LLC	31 Dec 2024
PERCEPTIVE ADVISORS LLC	2.4%	-65.7%	$43,290,927	-$82,061,910	7,412,830	-65.5%	Perceptive Advisors LLC	30 Jun 2025

Institutional Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	312,156,065	$2,459,923,997	-$41,517,408	$8,205,886	$8,575,156	$7.88	282
2025 Q2	319,344,550	$1,830,820,509	+$26,198,234	$1,428,558	$2,271,720	$5.73	269
2025 Q1	309,423,212	$2,526,512,925	+$26,438,324	$4,695,955	$3,083,280	$8.16	281
2024 Q4	305,140,281	$2,874,465,217	-$56,740,355	$4,848,418	$4,395,208	$9.42	286
2024 Q3	309,836,000	$3,309,105,094	-$75,379,629	$8,901,462	$5,512,725	$10.68	289
2024 Q2	315,168,068	$3,126,533,611	-$75,738,128	$2,590,112	$2,576,344	$9.92	256
2024 Q1	321,847,405	$3,791,483,281	+$26,707,749	$4,157,218	$5,197,336	$11.78	253
2023 Q4	318,908,725	$4,524,863,003	+$261,463,996	$8,711,241	$48,844,818	$14.19	226
2023 Q3	298,862,861	$3,633,462,965	-$93,168,939	$7,775,104	$12,448,192	$12.16	228
2023 Q2	307,102,100	$3,857,183,589	+$125,609,285	$4,265,376	$10,664,796	$12.56	212
2023 Q1	297,533,564	$3,299,196,032	+$66,985,676	$6,103,936	$3,907,007	$11.09	222
2022 Q4	292,444,452	$3,570,548,028	+$6,804,421	$6,256,404	$8,056,158	$12.21	225
2022 Q3	292,887,704	$3,053,948,950	-$136,712,515	$3,247,000	$5,741,000	$10.44	218
2022 Q2	305,130,656	$3,277,204,978	+$27,959,920	$2,342,000	$7,784,000	$10.74	197
2022 Q1	303,248,438	$2,872,272,289	+$16,415,995	$2,402,000	$2,946,000	$9.47	199
2021 Q4	301,421,729	$3,479,958,222	+$96,361,873	$3,477,000	$8,934,000	$11.55	215
2021 Q3	292,731,132	$2,798,448,068	+$153,922,424	$12,233,000	$17,775,000	$9.55	223
2021 Q2	276,914,599	$2,669,802,857	+$6,810,492	$4,184,000	$12,552,000	$9.64	222
2021 Q1	275,685,202	$2,723,386,669	-$230,544,914	$15,751,000	$24,352,940	$9.88	241
2020 Q4	279,155,505	$6,445,326,162	+$41,955,777	$69,441,819	$71,480,595	$23.09	267
2020 Q3	277,950,423	$3,923,978,054	-$60,291,396	$9,071,000	$32,766,000	$14.12	241
2020 Q2	281,585,235	$4,247,304,450	+$7,015,222	$3,253,000	$30,450,000	$15.08	217
2020 Q1	283,489,123	$2,618,877,274	+$72,473,358	$3,208,000	$12,396,000	$9.24	194
2019 Q4	275,145,261	$2,679,735,821	+$17,027,225	$4,341,000	$7,547,000	$9.74	211
2019 Q3	273,274,367	$2,191,232,241	+$7,544,973	$1,914,000	$6,777,000	$8.02	195
2019 Q2	268,775,703	$3,353,010,219	+$246,345,026	$9,467,000	$10,143,000	$12.48	202
2019 Q1	250,783,992	$3,410,473,734	+$284,627,731	$7,402,000	$19,877,000	$13.6	198
2018 Q4	231,135,366	$2,206,742,744	+$14,137,230	$2,541,000	$9,993,000	$9.58	182
2018 Q3	228,274,496	$2,760,074,376	-$4,704,604	$5,826,000	$37,868,000	$12.09	198
2018 Q2	226,320,420	$3,535,050,017	+$30,838,151	$8,111,000	$62,864,000	$15.62	196
2018 Q1	224,632,187	$3,376,722,825	+$286,532,653	$57,690,000	$91,679,000	$15.04	198
2017 Q4	205,784,956	$2,961,554,572	+$69,146,321	$66,612,000	$72,221,000	$14.39	181
2017 Q3	198,393,444	$2,990,825,396	+$373,880,068	$62,023,000	$54,684,000	$15.08	183
2017 Q2	174,164,391	$1,753,807,994	+$127,263,729	$8,299,000	$22,902,000	$10.07	138
2017 Q1	168,794,799	$1,203,523,835	+$168,107,989	$3,497,000	$3,902,000	$7.13	128
2016 Q4	156,858,667	$779,548,508	+$23,503,784	$2,202,000	$8,983,000	$4.97	130
2016 Q3	148,308,742	$1,096,923,417	+$112,419,698	$2,439,000	$10,085,000	$7.4	134
2016 Q2	136,917,771	$747,537,873	-$24,940,455	$1,669,000	$2,111,000	$5.46	124
2016 Q1	139,111,687	$1,175,012,113	+$7,378,238	$2,290,000	$17,864,000	$8.45	126
2015 Q4	138,735,633	$1,345,655,641	+$33,592,548	$3,093,000	$8,622,000	$9.7	136
2015 Q3	127,754,259	$1,760,477,682	+$206,267,066	$3,515,000	$7,192,000	$13.99	144
2015 Q2	112,532,503	$1,592,136,319	+$450,570,258	$6,021,000	$7,564,000	$14.15	137
2015 Q1	82,024,911	$890,563,041	+$47,434,297	$7,821,000	$8,236,000	$10.88	122
2014 Q4	79,806,156	$663,900,201	+$233,293,757	$3,686,000	$4,641,000	$8.32	109
2014 Q3	47,042,933	$279,906,000	+$43,116,058	$615,000	$1,809,000	$5.95	94
2014 Q2	40,677,308	$135,850,107	+$27,231,794	$0	$90,000	$3.34	60
2014 Q1	34,301,232	$71,016,802	-$323,725	$24,000	$84,000	$2.07	67